{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:51:44Z","timestamp":1783482704562,"version":"3.55.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/mph.0000000000000514","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T22:40:33Z","timestamp":1455748833000},"page":"e129-e132","source":"Crossref","is-referenced-by-count":47,"title":["Gorham-Stout Disease Successfully Treated With Sirolimus and Zoledronic Acid Therapy"],"prefix":"10.1097","volume":"38","author":[{"given":"Stuart L.","family":"Cramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold C.","family":"Merrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Pressey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210209","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ajmg.a.35406","article-title":". PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon.","volume":"158A","author":"Hopman","year":"2012","journal-title":"Am J Med Genet A"},{"key":"R2-28-20210209","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MPH.0b013e3181edb464","article-title":". Treatment of Gorham-Stout disease with zoledronic acid and interferon-alpha: a case report and literature review.","volume":"32","author":"Kuriyama","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"R3-28-20210209","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00256-012-1565-4","article-title":". Gorham-Stout disease and generalized lymphatic anomalyclinical, radiologic, and histologic differentiation.","volume":"42","author":"Lala","year":"2013","journal-title":"Skeletal Radiol"},{"key":"R4-28-20210209","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/pbc.24832","article-title":". Novel molecular pathways in Gorham disease: implications for treatment.","volume":"61","author":"Hagendoorn","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R5-28-20210209","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":". Sirolimus for the treatment of complicated vascular anomalies in children.","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R6-28-20210209","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pbc.22948","article-title":". Gorhams disease and diffuse lymphangiomatosis in children and adolescents.","volume":"56","author":"Venkatramani","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R7-28-20210209","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1651-2227.2011.02361.x","article-title":". A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax.","volume":"100","author":"Brodszki","year":"2011","journal-title":"Acta Paediatr"},{"key":"R8-28-20210209","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00402-008-0742-3","article-title":". Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome.","volume":"129","author":"Lehmann","year":"2009","journal-title":"Arch Orthop Trauma Surg"},{"key":"R9-28-20210209","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bone.2014.02.011","article-title":"Viewpoints on vessels and vanishing bones in Gorham-Stout disease.","volume":"63","author":"Dellinger","year":"2014","journal-title":"Bone"},{"key":"R10-28-20210209","doi-asserted-by":"crossref","first-page":"e39558","DOI":"10.1371\/journal.pone.0039558","article-title":". Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.","volume":"7","author":"Coso","year":"2012","journal-title":"PLoS One"},{"key":"R11-28-20210209","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/jmg.2007.048934","article-title":". The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management.","volume":"44","author":"Tan","year":"2007","journal-title":"J Med Genet"},{"key":"R12-28-20210209","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1158\/0008-5472.CAN-10-0578","article-title":". Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.","volume":"70","author":"Moriceau","year":"2010","journal-title":"Cancer Res"},{"key":"R13-28-20210209","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1359\/JBMR.041113","article-title":". Gorham-Stout diseasestabilization during bisphosphonate treatment.","volume":"20","author":"Hammer","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R14-28-20210209","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/pros.20752","article-title":". RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.","volume":"68","author":"Morgan","year":"2008","journal-title":"Prostate"},{"key":"R15-28-20210209","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":". Efficacy and safety of sirolimus in lymphangioleiomyomatosis.","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"R16-28-20210209","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4158\/EP14106.OR","article-title":". Comparison of the efficacy, adverse effects and cost of zoledronic acid and denosumab in the treatment of osteoporosis.","volume":"21","author":"Sheedy","year":"2015","journal-title":"Endocr Pract"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:48:06Z","timestamp":1620964086000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201604000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000514","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}